Most Active Biotech Investors in Durham 2026

5 firms writing Biotech checks in Durham, led by Alexandria Venture Investments, Bios Partners.

Biotech in Durham accounts for 4 tracked companies with verified cap-table data, 4 of which disclose round sizes totalling $823M. The median disclosed raise is $200M, and the largest is Vestaron at $285M, ahead of Abcuro ($200M) and Pairwise Plants ($180M).

The names that recur most often on these biotech cap tables are Pontifax (2 companies), Anterra Capital (1 company), CGC Ventures (1 company), Novo Holdings (1 company), NEA (1 company), Foresite Capital (1 company). By latest disclosed round, the market skews Series C (3), Series D (1).

Companies tracked: 4
Disclosed funding total: $823M across 4 companies
Median disclosed raise: $200M
Largest raise: Vestaron — $285M
Stage mix: Series C 3 · Series D 1
Most recent dated round: 2025-02-12

Best funded Biotech in Durham companies

Vestaron — $285M (latest: Series D)
Abcuro — $200M (latest: Series C)
Pairwise Plants — $180M (latest: Series C)
Atsena Therapeutics — $158M (latest: Series C)

Sector × city funding reports (20)

All research · Investor directory · Company funding database · Fundraising library